Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stellate Ganglion Block for the Treatment of COVID-19-Induced Parosmia: Double-Blinded, Placebo-Controlled Randomized Clinical Trial

NCT06253806 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT06253806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06253806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stellate Ganglion Block for the Treatment of COVID-19-Induced Parosmia: Double-Blinded, Placebo-Controlled Randomized Clinical Trial
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Completed
Start date
October 25, 2023
Completion date
September 16, 2024
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19-induced parosmia